Atlas Trials

Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI

Clinical trial NCT02263677 · WITHDRAWN

Trial details

NCT number
NCT02263677
Sponsor
University of Missouri-Columbia
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 DiabetesNon-alcoholic Fatty Liver Disease
Start date
2014-03-01
Primary completion
2015-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.